{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:43:26Z","timestamp":1780983806357,"version":"3.54.1"},"reference-count":52,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN2013\/671"],"award-info":[{"award-number":["CAN2013\/671"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["K2014-64X-05971-34-4"],"award-info":[{"award-number":["K2014-64X-05971-34-4"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2013-0045"],"award-info":[{"award-number":["PR2013-0045"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancerf\u00f6reningen i Stockholm","doi-asserted-by":"publisher","award":["111293"],"award-info":[{"award-number":["111293"]}],"id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BSRT, GSC203"],"award-info":[{"award-number":["BSRT, GSC203"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00795","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T03:58:29Z","timestamp":1499745509000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis"],"prefix":"10.3389","volume":"8","author":[{"given":"Arjang","family":"Baygan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wictor","family":"Aronsson-Kurttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babylonia","family":"Tibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Dahll\u00f6f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Klingspor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Khoein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotta","family":"Hausmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt-Marie","family":"Svahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Westgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1600-065X.1985.tb01160.x","article-title":"Graft-versus-host disease in dog and man: the Seattle experience","volume":"88","author":"Storb","year":"1985","journal-title":"Immunol Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00007890-198507000-00009","article-title":"Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy","volume":"40","author":"Ringd\u00e9n","year":"1985","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nm0402-410","article-title":"In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens","volume":"8","author":"Dickinson","year":"2002","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1182\/blood-2006-12-041889","article-title":"How I treat refractory acute GVHD","volume":"109","author":"Deeg","year":"2007","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/601953","article-title":"Steroid-refractory acute GVHD: predictors and outcomes","volume":"2011","author":"Westin","year":"2015","journal-title":"Adv Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.bbmt.2012.04.006","article-title":"Secondary treatment of acute graft-versus-host disease: a critical review","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B7","first-page":"529","article-title":"Hemorrhagic cystitis","volume-title":"Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians","author":"Pot\u00e1cov\u00e1","year":"2015"},{"key":"B8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/TP.0b013e3181ea4240","article-title":"Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT)","volume":"90","author":"Hoogduijn","year":"2010","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","article-title":"Immunomodulation by mesenchymal stem cells","volume":"2","author":"Le Blanc","year":"2007","journal-title":"J Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1038\/sj.leu.2404833","article-title":"Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon","volume":"21","author":"Ringd\u00e9n","year":"2007","journal-title":"Leukemia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2352-3026(15)00224-0","article-title":"Survival after mesenchymal stromal cell therapy in steroid refractory acute graft-versus-host disease. A systematic review and meta-analysis","volume":"3","author":"Hashmi","year":"2016","journal-title":"Lancet Haematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of severe refractory acute graft-versus-host disease","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s12185-012-1218-3","article-title":"Treatment of severe acute graft versus host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients","volume":"96","author":"Remberger","year":"2012","journal-title":"Int J Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.4049\/jimmunol.179.3.1595","article-title":"Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells","volume":"174","author":"Haniffa","year":"2007","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2141.2008.07492.x","article-title":"Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials","volume":"144","author":"Brooke","year":"2009","journal-title":"Br J Haematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","article-title":"Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta","volume":"22","author":"In \u2018t Anker","year":"2004","journal-title":"Stem Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2249.2011.04540.x","article-title":"Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro","volume":"167","author":"Karlsson","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/stem.1314","article-title":"Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease","volume":"31","author":"Ringd\u00e9n","year":"2013","journal-title":"Stem Cells"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1089\/scd.2013.0079","article-title":"Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner","volume":"22","author":"Erkers","year":"2013","journal-title":"Stem Cells Dev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1089\/scd.2015.0120","article-title":"Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua","volume":"24","author":"Moll","year":"2015","journal-title":"Stem Cells Dev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1089\/scd.2015.0329","article-title":"Effects of freeze-thawing and intravenous infusions of mesenchymal stromal cell gene expression","volume":"25","author":"Hoogduijn","year":"2016","journal-title":"Stem Cell Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility system","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.bbmt.2014.06.015","article-title":"Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease","volume":"20","author":"S\u00e1nchez-Guijo","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B28","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","article-title":"A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group","volume":"83","author":"Ringd\u00e9n","year":"1994","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1000142","DOI":"10.4172\/2161-0991.1000142","article-title":"Decreased risk of acute graft-versus-host disease using reduced intensity conditioning compared to myeloablative conditioning is independent of donor-recipient T-cell chimerism","volume":"4","author":"Ringd\u00e9n","year":"2014","journal-title":"J Transpl Technol Res"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial","volume":"73","author":"Storb","year":"1989","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3324\/haematol.2016.149294","article-title":"A prospective randomized trial comparing cyclosporine\/methotrexate and tacrolimus\/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation","volume":"101","author":"T\u00f6rl\u00e9n","year":"2016","journal-title":"Hematologica"},{"key":"B33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/bmt.2008.239","article-title":"Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor","volume":"42","author":"Ringd\u00e9n","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1182\/blood-2002-03-0801","article-title":"Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care","volume":"100","author":"Svahn","year":"2002","journal-title":"Blood"},{"key":"B35","first-page":"619","article-title":"Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings","volume":"15","author":"Ringd\u00e9n","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"B36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1600-0609.2012.01824.x","article-title":"Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation","volume":"89","author":"Forsl\u00f6w","year":"2012","journal-title":"Eur J Haematol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/bmt.2010.262","article-title":"Pooled MSCs for treatment of severe hemorrhage","volume":"46","author":"Ringden","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B39","volume-title":"WHO Handbook for Reporting Results for Cancer Treatment","year":"1979"},{"key":"B40","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V77.5.1104.1104","article-title":"Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique","volume":"77","author":"Einsele","year":"1991","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3324\/haematol.2013.087338","article-title":"Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation","volume":"99","author":"Uhlin","year":"2014","journal-title":"Haematologica"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1089\/scd.2011.0310","article-title":"Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantation","volume":"21","author":"Uhlin","year":"2012","journal-title":"Stem Cells Dev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00277-013-1957-0","article-title":"Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"93","author":"Ayuk","year":"2014","journal-title":"Ann Hematol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cells"},{"key":"B46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/scd.2014.0265","article-title":"Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with 111Indium radiolabeling","volume":"24","author":"Erkers","year":"2015","journal-title":"Stem Cells Dev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/bmt.2013.237","article-title":"Stromal cells-are they really useful for GVHD?","volume":"49","author":"Kaipe","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.2337\/db13-0896","article-title":"Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity","volume":"62","author":"Acosta","year":"2013","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e42819","DOI":"10.1371\/journal.pone.0042819","article-title":"Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity","volume":"7","author":"Stephenne","year":"2012","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1182\/blood-2007-10-119370","article-title":"Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses","volume":"112","author":"Karlsson","year":"2008","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","article-title":"Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy","volume":"18","author":"von Bahr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4172\/2157-7633.1000244","article-title":"Successful reversal of acute lung injury using placenta-derived decidual stromal cells","volume":"4","author":"Ringd\u00e9n","year":"2014","journal-title":"J Stem Cell Res Therapy"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00795\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T23:44:54Z","timestamp":1602459894000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00795\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2017.00795"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00795","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,11]]},"article-number":"795"}}